Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

The ability of Natural Killer (NK) cells to kill tumor targets has been extensively studied in various hematological malignancies. However, NK cell therapy directed against solid tumors is still in early development. Epidermal Growth Factor Receptor (EGFR) targeted therapies using monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L., Heideman, Daniëlle A. M., Verheul, Henk M. W., de Gruijl, Tanja D., van der Vliet, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912059/
https://www.ncbi.nlm.nih.gov/pubmed/27314237
http://dx.doi.org/10.1371/journal.pone.0157830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912059/
https://www.ncbi.nlm.nih.gov/pubmed/27314237
http://dx.doi.org/10.1371/journal.pone.0157830

Ejemplares similares